192 related articles for article (PubMed ID: 27136492)
1. Apparent 'JAK2-negative' polycythaemia vera due to compound mutations in exon 14.
Tiong IS; Casolari DA; Moore S; Nguyen T; Van Velzen MJM; Zantomio D; Scott HS; D'Andrea RJ; Hahn CN; Ross DM
Br J Haematol; 2017 Jul; 178(2):333-336. PubMed ID: 27136492
[No Abstract] [Full Text] [Related]
2. High frequency of JAK2 exon 12 mutations in Korean patients with polycythaemia vera: novel mutations and clinical significance.
Park CH; Lee KO; Jang JH; Jung CW; Kim JW; Kim SH; Kim HJ
J Clin Pathol; 2016 Aug; 69(8):737-41. PubMed ID: 27198504
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
Lakey MA; Pardanani A; Hoyer JD; Nguyen PL; Lasho TL; Tefferi A; Hanson CA
Am J Clin Pathol; 2010 Jun; 133(6):942-8. PubMed ID: 20472853
[TBL] [Abstract][Full Text] [Related]
4. Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.
Kouroupi E; Zoi K; Parquet N; Zoi C; Kiladjian JJ; Grigoraki V; Vainchenker W; Lellouche F; Marzac C; Schlageter MH; Dosquet C; Scott LM; Fenaux P; Loukopoulos D; Chomienne C; Cassinat B
Br J Haematol; 2008 Aug; 142(4):676-9. PubMed ID: 18503583
[No Abstract] [Full Text] [Related]
5. Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera.
Nussenzveig RH; Burjanivova T; Salama ME; Ogilvie NW; Marcinek J; Plank L; Agarwal AM; Perkins SL; Prchal JT
Leuk Lymphoma; 2012 Dec; 53(12):2479-86. PubMed ID: 22642932
[TBL] [Abstract][Full Text] [Related]
6. Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms.
Kucine N; Al-Kawaaz M; Hajje D; Bussel J; Orazi A
Br J Haematol; 2019 Apr; 185(1):136-139. PubMed ID: 29767848
[No Abstract] [Full Text] [Related]
7. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels.
Percy MJ; Scott LM; Erber WN; Harrison CN; Reilly JT; Jones FG; Green AR; McMullin MF
Haematologica; 2007 Dec; 92(12):1607-14. PubMed ID: 18055983
[TBL] [Abstract][Full Text] [Related]
8. Quantitative bead-based assay for detection of JAK2 exon 12 mutations.
Shivarov V; Ivanova M; Yaneva S; Petkova N; Hadjiev E; Naumova E
Leuk Lymphoma; 2013 Jun; 54(6):1343-4. PubMed ID: 23121686
[No Abstract] [Full Text] [Related]
9. Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations.
Ibrahim IK; Hassan R; Ali EW; Omer A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):41-44. PubMed ID: 30677867
[TBL] [Abstract][Full Text] [Related]
10. Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.
Hussein K; Brakensiek K; Buesche G; Buhr T; Wiese B; Kreipe H; Bock O
Ann Hematol; 2007 Apr; 86(4):245-53. PubMed ID: 17262192
[TBL] [Abstract][Full Text] [Related]
11. JAK2 exon 12 mutation in JAK2V617F-negative polycythemia vera.
Röthlisberger B; Huber A; Bargetzi M; Mendez A; Heizmann M
Leuk Lymphoma; 2008 Mar; 49(3):586-8. PubMed ID: 18297539
[No Abstract] [Full Text] [Related]
12. Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis.
Ohyashiki JH; Hisatomi H; Shimizu S; Sugaya M; Ohyashiki K
Jpn J Clin Oncol; 2009 Aug; 39(8):509-13. PubMed ID: 19491085
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis.
Cazzola M
Haematologica; 2007 Dec; 92(12):1585-9. PubMed ID: 18055979
[No Abstract] [Full Text] [Related]
14. Infrequent occurrence of MPL exon 10 mutations in polycythemia vera and post-polycythemia vera myelofibrosis.
Pardanani A; Lasho TL; Finke CM; Tefferi A
Am J Hematol; 2011 Aug; 86(8):701-2. PubMed ID: 21674576
[No Abstract] [Full Text] [Related]
15. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.
Schnittger S; Bacher U; Haferlach C; Geer T; Müller P; Mittermüller J; Petrides P; Schlag R; Sandner R; Selbach J; Slawik HR; Tessen HW; Wehmeyer J; Kern W; Haferlach T
Haematologica; 2009 Mar; 94(3):414-8. PubMed ID: 19252176
[TBL] [Abstract][Full Text] [Related]
16. After 10years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera.
Grinfeld J; Godfrey AL
Blood Rev; 2017 May; 31(3):101-118. PubMed ID: 27884555
[TBL] [Abstract][Full Text] [Related]
17. The role of a low erythropoietin level in the diagnosis of JAK2 exon 12-mutated polycythemia vera.
Langabeer SE
Blood Cells Mol Dis; 2020 Feb; 80():102377. PubMed ID: 31655393
[No Abstract] [Full Text] [Related]
18. [Not Available].
Bächli E; Gundelfinger M
Praxis (Bern 1994); 2017 Jul; 106(15):807-813. PubMed ID: 28745110
[No Abstract] [Full Text] [Related]
19. Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera.
Scott LM; Beer PA; Bench AJ; Erber WN; Green AR
Br J Haematol; 2007 Nov; 139(3):511-2. PubMed ID: 17910642
[No Abstract] [Full Text] [Related]
20. Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: report of a new mutation.
Bernardi M; Ruggeri M; Albiero E; Madeo D; Rodeghiero F
Am J Hematol; 2009 Apr; 84(4):258-60. PubMed ID: 19229983
[No Abstract] [Full Text] [Related]
[Next] [New Search]
